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Background: The uterine endometrial polyp (EMP) has a potential risk of developing malignant tumors especially
in postmenopausal women. These malignancies include endometrial intraepithelial carcinoma (EIC).
Patients and methods: Eight patients with EIC in the EMP, who were postmenopausal with ages ranging from 49
to 76 years (av. 62), were cytologically reviewed in comparison with histological findings.
Results: The endometrial cytological findings were summarized as follows: mucous and watery diathesis as a
background lacking or with little necrotic inflammatory changes; micropapillary cluster formation; abrupt transition
between carcinoma cells and normal cells; nuclear enlargement; high N/C ratio; and single or a few prominent
nucleoli. Histologically, one case had EIC alone in the EMP; three cases had EIC with stromal invasion confined to
the EMP; and four cases had EIC in the atrophic endometrium in addition to EIC in the EMP. Seven patients have
taken a disease-free course after surgical resection, but one patient died 44 months following the initial diagnosis
because of the massive tumor extending over her peritoneal cavity.
Conclusions: Endometrial cytology may be helpful for the detection of early endometrial adenocarcinomas with
serous features including EIC. Some early stage endometrial adenocarcinomas represented by EIC exceptionally take
an aggressive clinical course irrespective of a lack of extrauterine lesions.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1651876760876449
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The uterine body type II cancers are histogenetically
distinguished from type I cancers with a background of
glandular hyperplasia which is in association with the
genetic alterations represented by PTEN inactivation [1].
Tumor development of uterine body serous adenocarcin-
oma, categorized as the type II group, has been clarified to
be linked with a putative precursor lesion designated as
endometrial intraepithelial carcinoma (EIC) [2-4]. EIC has
been alternatively regarded as in situ serous adenocarcin-
oma [5,6] and is considered to usually occur in the setting
of inactive or resting endometrium and frequently
involves endometrial polyp (EMP) [3]. Many minimal* Correspondence: m_yasuda@saitama-med.ac.jp
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reproduction in any medium, provided the orserous adenocarcinomas, defined as limited to the endo-
metrium and less than 1 cm [7], are also found to
frequently have EIC and involve EMP [8]. However, the
nomenclature of EIC remains controversial because
there are morphological variations in the endometrial
intraepithelial precancerous lesion, and EIC is known to
be potentially complicated with the extrauterine lesion.
Therefore, instead of EIC, a newly defined terminology
of endometrial glandular dysplasia has been proposed
[9]. Reportedly, 10–34% of endometrial cancers in
postmenopausal women have been associated with
EMPs [10]. Usually, the major adenocarcinomas are the
endometrioid type and the second major adenocarcin-
omas are the serous type [10]. The eight cases with early
endometrial carcinoma of the uterine body, characterized
by EIC being associated with EMP, were subjected to close
cytological review as well as histological review. For them,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the inner location of tumors at the fundus and their small
size. However, the endometrial cytological approach is
supposed to be of help for the detection of these early
lesions. The candidates of differential cytological diagnosis
for these cases are advanced serous adenocarcinoma, clear
cell adenocarcinoma, high grade endometrioid adenocar-
cinoma and also low grade endometrioid adenocarcinoma
[11]. Immigration of ovarian carcinoma via the fallopian
tube, instead of metastasizing to the endometrium, is also
included in the differential diagnoses [12].
Patients
The eight patients were postmenopausal, with ages ranging
from 49 to 76 years (av. 62) when the cytological abnormal-
ities were initially recognized. All of them visited their
neighboring hospitals with a chief complaint of irregular
genital bleeding. One patient had received surgical treat-
ment for breast cancer 6 years before and had been
administered an anti-estrogenic drug (Tamoxifen). There
was no past history of other malignancies in the remaining
patients. The endometrial cytology using EndocyteW (MSD
Co., Tokyo, Japan) suspected adenocarcinoma which was
consistent with being at the early stage, including EIC, for
all the patients. However, the endometrial biopsy did not
lead to the confirmation of malignancy except in two
patients for whom the diagnosis was adenocarcinoma,
although the adenocarcinoma could not be specified be-
cause the specimen was too small. They all underwent total
abdominal hysterectomy and bilateral adnexectomy. Re-
gional lymph node dissection was performed in three of the
patients, resulting in no evidence of metastatic lesions. In
two patients for whom polypectomy with hysteroscopic
assistance had been performed previously, no residual
carcinoma was found in the hysterectomy specimen.
Results
The EMPs including EIC with / without stromal invasion




1 61 watery micropapilla
2 63 watery micropapilla
3 76 bloody sheet-like
4 60 watery micropapilla
5 61 bloody micropapilla
6 65 watery sheet-like
7 49 watery micropapilla
8 62 watery micropapilla
a: average of largest diameter of tumor cells (relative value compared to normal nupatients. The cytological features are summarized in
Table 1 and representatively depicted in Figures 1, 2, and
3, including histological findings of three patients. The
tumor diathesis was characterized as being predominantly
mucous for 3 patients, watery for 3 patients, and bloody
for 2 patients, but with no prominent necrotic inflamma-
tory changes. The tumor cell clusters predominantly took
a micropapillary pattern and occasionally a sheet-like
pattern. Overlapping of the tumor cell nuclei was noted in
a variable degree: often for 2 patients, and occasionally for
5 patients. There were varying amounts of normal epithe-
lial cells, which served as a hallmark in distinction from
the malignancy because of a significant difference in the
nuclear size. Using Isis ver. 5 (MetaSystems GmbH,
Altlussheim, Germany), the nuclear size (greatest diam-
eter) of tumor cells were measured as well as normal
atrophic cells in the cytological preparations. The
numbers of counted cells for the former and the latter
ranged from 50 to 70 in each case. On the total average of
8 cases, the tumor cell size was 12.5 μm and the relative
ratio to the corresponding normal atrophic cells was 2.3
(Table 1). The chromatin was considerably dense, coarse
or granular. The number of prominent nucleoli was as
follows: 1 for 4 patients; 1 or 2 for 4 patients. Calcified
deposits of psammoma body were not apparently observed
in any patient.
The clinicopathological profiles are summarized in
Table 2. All the patients had an EMP in which atypical
tumor cells were arranged predominantly in a tubular
structure with micropapillary protrusions, replacing the
pre-existing endometrial glands. Micropapillary protrusions
and small tufts were accompanied with or without thin
fibrovascular cores. These tumor cells showed conspicuous
nuclear pleomorphism and hyperchromatism, frequent
mitotic figures, high N/C ratio, and also one or two prom-
inent nucleoli. The tumor front was abruptly made into
normal glandular epithelium and surface-lining epithelium
in the EMP. Minimal stromal invasion of the tumor cells
limited to the EMP was recognized in 3 patients. Inrcinomas
Nucleus Nucleolus
Overlapping aSize: μm Number
ry often 12.3 (2.3) 1~2
ry often 11.3 (2.1) 1~2
occasional 12.8 (2.1) 1~2
ry occasional 12.9 (2.3) 1
ry occasional 11.3 (2.4) 1
rare 14.8 (2.8) 1
ry occasional 10.6 (2.2) 1





Figure 1 Case 2 possessing EIC in both endometrial polyp and endometrium (A. Pap × 20, B. Pap × 60, C. loupe view, D. HE × 20,
E. HE × 60, F. HE × 60). A. Papillary-structured carcinoma cell cluster is accompanied by a watery background (Pap. ×20). B. The N/C ratio is fairly
high and the chromatin is coarsely granular (Pap. ×60). C. Loupe findings show an endometrial polyp arising in the uterine fundus, measuring
1.5 cm in longitudinal length. The endometrium is markedly thin and atrophic. The area marked by an arrow and that marked by an arrowhead
are depicted respectively in E and F. D. In the polyp, the glands composed of carcinoma cells are found to be aggregated in the fibrotic stroma.
E. Carcinoma cells are replacing the glands in the polyp and stratified into micropapillary protrusions, lacking apparent stromal invasion (HE × 20).
F. Carcinoma nests similar to those in the endometrial polyp (D) are also present in the endometrial gland (HE × 60).
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some atrophic endometrial glands in 4 patients, lacking
stromal invasion. In the background, cystic dilatation of
atrophic normal glands was evident especially in the EMP.
Immunohistochemical expressions of p53 (DO7, 1:50,
Dako, Glostrup, Denmark), Ki-67 (MIB-1, 1:100, Dako,
Glostrup, Denmark), ER (SP-1, 1:1, Ventana, AZ, USA),
and PgR (1E2, 1:1, Ventana, AZ, USA) were examined
(Figure 4). Six patients showed marked p53 expression
with a positive ratio of more than 80%. The labeling index
of Ki-67 ranged from 25 to 70% (av. approximately 40).
ER was mildly expressed in one patient and PgR expres-
sion also was mildly observed in 2 patients.FIGO stage was determined at IA for all the patients.
Neither adjuvant chemotherapy nor irradiation was
performed. Seven patients have been taking an uneventful
clinical course (follow-up period ranging from 12 to
66 months, av. 41), but one patient died of the recurrent
disease massively occupying the abdominal cavity 44 -
months after the initial diagnosis.
Discussion
Endometrial polyp is a common benign disease of the
uterus. The overall incidence where cancer arises in the
endometrial polyp has been reported as only a few per-
cent, while postmenopausal women with EMP are at an
A B
DC
Figure 2 Case 5 possessing EIC in both endometrial polyp and endometrium, but with stromal invasion in the polyp (A. Pap × 20,
B. Pap × 60, C. HE × 20, D. HE × 60). A. A carcinoma cell cluster is accompanied by a bloody background. B. Carcinoma cells having enlarged
nuclei appear to be transitional with normal atrophic cells having small-sized nuclei (arrows). C. The polyp has many atypical glands with
intraluminal papillary protrusion of the carcinoma cells. D. The border between the carcinoma cells and normal cells is clearly discernible (arrows).
There are small carcinoma nests showing stromal invasion (arrowheads).
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women [10,13-15]. As risk factors for development of the
malignancy in EMP, hypertension, obesity, and unopposed
estrogen therapy have been indicated in addition to
postmenopausal status [15]. There are unique or specific
pathological and clinical features for EIC as a putative
precursor of uterine body serous adenocarcinoma, as
follows [1,4,5,7,16-20]: close association with an EMP;
multicentric occurrence in the inactive or resting thin
endometrium, lacking alteration in the architecture in the
endometrium lacking an intervening phase of endometrial
hyperplasia; extrauterine invasive extent, irrespective of an
absence of stromal invasion of the uterus; and controver-
sial outcome, whether taking a favorable or unfavorable
clinical course. Development of EIC associated with an
EMP may also be explained in part by Tamoxifen adminis-
tration following breast cancer treatment [6,17]. However,
little has been documented about the endometrial cyto-
logical features of minimal serous adenocarcinoma of the
uterine body including EIC, mainly due to the fact that
the disease is not frequently encountered in the routine
practice. To the best of our knowledge, there is a case
report cytologically referring to serous adenocarcinoma
of the uterine body associated with an EMP [21], but
here the patient already showed peritoneal dissemin-
ation at the initial presentation. In another report,serous adenocarcinomas of the uterine body were
clinico-cytologically reviewed but they were all at
advanced stages [22]. The latter report mentions that
cytologically diagnostic findings of uterine body serous
adenocarcinoma would be based on the following
features: papillary cluster as well as tubular cluster,
arborescent structure, frequent exfoliation, psammoma
body, eccentric enlarged nuclei, coarsely granular chro-
matin, numerous nucleoli, and diameter of greater than
G1 endometrioid adenocarcinoma [22]. In our review,
5 patients were purely non-invasive as they were
composed of only EIC existing in an EMP, with few
or no necroinflammatory changes. The background
was found to be characteristically watery or mucous
(Figure 1) in a way of simulating the immigration of
extrauterine carcinoma cells via the fallopian tubes [12].
Many clusters were arranged in micropapillary architec-
ture without fine vascular stroma, and others were occa-
sionally tubular. An abrupt transition between the EIC
cells and atrophic endometrial cells was noted by front
formation (Figure 2). Conspicuous nucleoli were found
in 3 patients (Figure 3). Even though it seems difficult to
reach a definite diagnosis, these findings may serve as a
diagnostic indicator for the uterine body serous ade-




Figure 3 Case 6 possessing EIC confined to endometrial polyp (A. Pap × 20, B. Pap × 60, C. HE × 60, D. HE × 60). A. Large-sized carcinoma
cell clusters are accompanied by a non-necroinflammatory background. B. Carcinoma cells mainly appear in a flat and sheet-like cluster. The
nucleus has an enlarged eosinophilic nucleolus. C. The atypical glands are normal-sized, accompanied by cystic dilatation of atrophic normal
glands. D. Carcinoma cells are replacing pre-existing glands and are arranged in a single layer (compare with normal gland marked by an arrow).
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the normal-appearing endometrial background include
variable interpretations as follows: EIC, endometrial
glandular dysplasia, endometrial intraepithelial neopla-
sia, hyperplastic polyp, and metastatic carcinoma [9,23].
In addition to these, isolated atypical glands with
morphological and immunohistochemical features of aTable 2 Clinicopathological profiles of endometrial intraepith
Case EIC location Immunohistochemistry
P53a MIB-1b
1 polyph + 30
2 polyp & endometrium + 60
3f polyp & endometrium + 35
4 polyp + 30
5 polyph & endometrium + 45
6 polyp + 25
7 g polyp - 30
8 polyph & endometrium - 70
a:+, strongly positive cells more than 80%.
b: index of positive cells(%), c: +, positive cells more than 80%.
d: +, positive cells more than 80%.
e: since initial diagnosis.
f: history of breast cancer with Tamoxifen administration.
g: autopsy performed.
h: with stromal invasion, i: disease free, j: death on disease.typical endometrial hyperplasia or type I endometrial
adenocarcinoma may be encountered in grossly normal
postmenopausal endometrium of asymptomatic patients
[24]. Especially in the postmenopausal state, thin and
smooth endometrium with atrophy is composed of
hypocellular and flattened glands lined by cells with
reduced or absent mitosis and sparse fibrous stromaelial carcinomas
FIGO stage Outcome (periode)
ERc PgRd
+ + IA DFi (66 months)
- - IA DF (65 months)
- - IA DF (36 months)
- - IA DF (30 months)
- + IA DF (39 months)
- - IA DF (39 months)
- - IA DODj (44 months)
- - IA DF (12 months)
A B
DC
Figure 4 Immunohistochemical staining profiles represented by Case 5 (A. p53 × 40, B. MIB-1 × 40, C. ER × 20, D. PgR × 20). A. Almost all
of the carcinoma cells are strongly positive. B. More than half the carcinoma cells are labeled. C. The expression is observed in the cystically
dilated normal glands and stromal cells but not in the carcinoma cells. D. The expression behavior is basically similar to the ER expression.
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atrophic endometrial cells to atypical cells may indicate
EIC in postmenopausal women.
Overexpression of p53 is closely linked to the rapid
growth of uterine body serous adenocarcinoma [6]. In EIC,
too, frequent p53 mutation is reported to be associated with
LOH of 17p [26]. Thus, immunohistochemistry for p53 is
also adjunctively available in the diagnosis of uterine body
serous adenocarcinoma, irrespective of whether it is at an
early stage or advanced stage [27], in the discrimination
between uterine body serous adenocarcinoma and benign
morphologic mimics [28]. Negativity of ER and PgR
staining is more reasonable with the diagnosis of serous
adenocarcinoma including EIC.
In summary, EMP arising in postmenopausal women is
at a high risk of giving birth to the tumorigenetic back-
ground for endometrial carcinomas such as endometrioid
adenocarcinoma and serous adenocarcinoma including
EIC. Endometrial cytology may become a helpful diag-
nostic approach for serous adenocarcinoma, whether it is
at early or advanced stage, from the viewpoint of the
distinctive cytological features. Above all, it should be
noted that some EIC behaves in a more aggressive fashion
regardless of whether or not it lacks apparent stroma inva-
sion and extrauterine extent.Patients’ consents
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